Abstract
Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1-8 |
| Number of pages | 8 |
| Journal | Journal of Asthma and Allergy |
| Issue number | 3 |
| State | Published - 2010 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Pulmonary and Respiratory Medicine
Cite this
Current trends in the treatment of asthma : Focus on the simultaneous administration of salmeterol/fluticasone. / Teply, Robyn; Campbell, Jennifer; Hilleman, Daniel E.
In: Journal of Asthma and Allergy, No. 3, 2010, p. 1-8.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Current trends in the treatment of asthma
T2 - Focus on the simultaneous administration of salmeterol/fluticasone
AU - Teply, Robyn
AU - Campbell, Jennifer
AU - Hilleman, Daniel E.
PY - 2010
Y1 - 2010
N2 - Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy.
AB - Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy.
UR - http://www.scopus.com/inward/record.url?scp=77953469231&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953469231&partnerID=8YFLogxK
M3 - Review article
SP - 1
EP - 8
JO - Journal of Asthma and Allergy
JF - Journal of Asthma and Allergy
SN - 1178-6965
IS - 3
ER -